118 related articles for article (PubMed ID: 11162037)
1. Immunohistochemistry and molecular detection of nodal micrometastases in pancreatic cancer.
Brown HM; Ahrendt SA; Komorowski RA; Doffek KM; Wilson SD; Demeure MJ
J Surg Res; 2001 Feb; 95(2):141-6. PubMed ID: 11162037
[TBL] [Abstract][Full Text] [Related]
2. Adenocarcinoma of the pancreas: detection of occult metastases in regional lymph nodes by a polymerase chain reaction-based assay.
Demeure MJ; Doffek KM; Komorowski RA; Wilson SD
Cancer; 1998 Oct; 83(7):1328-34. PubMed ID: 9762933
[TBL] [Abstract][Full Text] [Related]
3. Molecular metastases in stage I pancreatic cancer: improved survival with adjuvant chemoradiation.
Demeure MJ; Doffek KM; Komorowski RA; Redlich PN; Zhu YR; Erickson BA; Ritch PS; Pitt HA; Wilson SD
Surgery; 1998 Oct; 124(4):663-9. PubMed ID: 9780986
[TBL] [Abstract][Full Text] [Related]
4. The prognostic importance of immunohistochemically detected node metastases in resected esophageal adenocarcinoma.
Waterman TA; Hagen JA; Peters JH; DeMeester SR; Taylor CR; Demeester TR
Ann Thorac Surg; 2004 Oct; 78(4):1161-9; discussion 1161-9. PubMed ID: 15464464
[TBL] [Abstract][Full Text] [Related]
5. Pancreatic lymph nodal and plexus micrometastases detected by enriched polymerase chain reaction and nonradioisotopic single-strand conformation polymorphism analysis: a new predictive factor for recurrent pancreatic carcinoma.
Tamagawa E; Ueda M; Takahashi S; Sugano K; Uematsu S; Mukai M; Ogata Y; Kitajima M
Clin Cancer Res; 1997 Nov; 3(11):2143-9. PubMed ID: 9815608
[TBL] [Abstract][Full Text] [Related]
6. [Comparative study for detecting micrometastases of lymph nodes in patients with lung cancer].
Wang YX; Sun YE; Li XH; Wang ZB; Liu YL; Chen LA; Tong XY
Zhonghua Yi Xue Za Zhi; 2008 Jan; 88(1):19-21. PubMed ID: 18346373
[TBL] [Abstract][Full Text] [Related]
7. [Clinical pathological study on nodal micrometastases of non-small-cell lung cancer].
Wang YX; Chu XY; Sun YE; Wang ZB; Li XH; Zhang GK
Zhonghua Wai Ke Za Zhi; 2007 Jan; 45(2):114-7. PubMed ID: 17418040
[TBL] [Abstract][Full Text] [Related]
8. Ki-ras codon 12 point and P53 mutations: a molecular examination of the main tumor, liver, portal vein, peripheral arterial blood and para-aortic lymph node in pancreatic cancer.
Yamaguchi K; Chijiiwa K; Torato N; Kinoshita M; Tanaka M
Am J Gastroenterol; 2000 Aug; 95(8):1939-45. PubMed ID: 10950039
[TBL] [Abstract][Full Text] [Related]
9. Prognostic implications of routine, immunohistochemical, and molecular staging in resectable pancreatic adenocarcinoma.
Niedergethmann M; Rexin M; Hildenbrand R; Knob S; Sturm JW; Richter A; Post S
Am J Surg Pathol; 2002 Dec; 26(12):1578-87. PubMed ID: 12459624
[TBL] [Abstract][Full Text] [Related]
10. Prognostic value of nodal micrometastases in patients with cancer of the gastro-oesophageal junction.
Heeren PA; Kelder W; Blondeel I; van Westreenen HL; Hollema H; Plukker JT
Eur J Surg Oncol; 2005 Apr; 31(3):270-6. PubMed ID: 15780562
[TBL] [Abstract][Full Text] [Related]
11. Prognostic impact of micrometastases in colon cancer: interim results of a prospective multicenter trial.
Bilchik AJ; Hoon DS; Saha S; Turner RR; Wiese D; DiNome M; Koyanagi K; McCarter M; Shen P; Iddings D; Chen SL; Gonzalez M; Elashoff D; Morton DL
Ann Surg; 2007 Oct; 246(4):568-75; discussion 575-7. PubMed ID: 17893493
[TBL] [Abstract][Full Text] [Related]
12. Occult metastases in axillary lymph nodes as a predictor of survival in node-negative breast carcinoma with long-term follow-up.
Reed W; Bøhler PJ; Sandstad B; Nesland JM
Breast J; 2004; 10(3):174-80. PubMed ID: 15125740
[TBL] [Abstract][Full Text] [Related]
13. Lymph node isolated tumor cells and micrometastases in pathological stage I non-small cell lung cancer: prognostic significance.
Rena O; Carsana L; Cristina S; Papalia E; Massera F; Errico L; Bozzola C; Casadio C
Eur J Cardiothorac Surg; 2007 Dec; 32(6):863-7. PubMed ID: 17936004
[TBL] [Abstract][Full Text] [Related]
14. K-ras codon 12 and 13 mutations are correlated with differential patterns of tumor cell dissemination in colorectal cancer patients.
Conzelmann M; Linnemann U; Berger MR
Int J Oncol; 2004 Jun; 24(6):1537-44. PubMed ID: 15138598
[TBL] [Abstract][Full Text] [Related]
15. Mutations in the Kirsten-ras oncogene are common but lack correlation with prognosis and tumor stage in human pancreatic carcinoma.
Motojima K; Urano T; Nagata Y; Shiku H; Tsunoda T; Kanematsu T
Am J Gastroenterol; 1991 Dec; 86(12):1784-8. PubMed ID: 1962623
[TBL] [Abstract][Full Text] [Related]
16. [Detection of micrometastases after curative resection for ductal adenocarcinoma of the pancreas].
Niedergethmann M; Rexin M; Knob S; Hartel M; Sturm JW; Richter A; Post S
Zentralbl Chir; 2001 Nov; 126(11):917-21. PubMed ID: 11753804
[TBL] [Abstract][Full Text] [Related]
17. The prognostic effect of micrometastases in previously staged lymph node negative (N0) colorectal carcinoma: a meta-analysis.
Iddings D; Ahmad A; Elashoff D; Bilchik A
Ann Surg Oncol; 2006 Nov; 13(11):1386-92. PubMed ID: 17009147
[TBL] [Abstract][Full Text] [Related]
18. Accuracy of staging node-negative pancreas cancer: a potential quality measure.
Tomlinson JS; Jain S; Bentrem DJ; Sekeris EG; Maggard MA; Hines OJ; Reber HA; Ko CY
Arch Surg; 2007 Aug; 142(8):767-723; discussion 773-4. PubMed ID: 17709731
[TBL] [Abstract][Full Text] [Related]
19. Detection of K-ras mutations in the plasma DNA of pancreatic cancer patients.
Uemura T; Hibi K; Kaneko T; Takeda S; Inoue S; Okochi O; Nagasaka T; Nakao A
J Gastroenterol; 2004 Jan; 39(1):56-60. PubMed ID: 14767735
[TBL] [Abstract][Full Text] [Related]
20. Impact of total lymph node count and lymph node ratio on staging and survival after pancreatectomy for pancreatic adenocarcinoma: a large, population-based analysis.
Slidell MB; Chang DC; Cameron JL; Wolfgang C; Herman JM; Schulick RD; Choti MA; Pawlik TM
Ann Surg Oncol; 2008 Jan; 15(1):165-74. PubMed ID: 17896141
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
